对黏菌素耐药的鲍曼不动杆菌改变其抗生素耐药谱：来自西班牙的病例报告。 - Suppr

Suppr

超能文献

Acinetobacter baumannii resistant to colistin alters its antibiotic resistance profile: a case report from Spain.

作者信息

López-Rojas Rafael, Jiménez-Mejías Manuel Enrique, Lepe José Antonio, Pachón Jerónimo

出版信息

J Infect Dis. 2011 Oct 1;204(7):1147-8. doi: 10.1093/infdis/jir476.

DOI:10.1093/infdis/jir476

PMID:21881133

Abstract

摘要

相似文献

Acinetobacter baumannii resistant to colistin alters its antibiotic resistance profile: a case report from Spain.

J Infect Dis. 2011 Oct 1;204(7):1147-8. doi: 10.1093/infdis/jir476.

Acinetobacter baumannii resistant to colistin with impaired virulence: a case report from France.

J Infect Dis. 2011 Oct 1;204(7):1146-7. doi: 10.1093/infdis/jir475.

Synergistic activity of sulbactam combined with colistin against colistin-resistant Acinetobacter baumannii.

Int J Antimicrob Agents. 2012 Feb;39(2):180-1. doi: 10.1016/j.ijantimicag.2011.10.001. Epub 2011 Nov 17.

Emergence of colistin resistance without loss of fitness and virulence after prolonged colistin administration in a patient with extensively drug-resistant Acinetobacter baumannii.

Diagn Microbiol Infect Dis. 2015 Jul;82(3):222-6. doi: 10.1016/j.diagmicrobio.2015.03.013. Epub 2015 Mar 25.

Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii.

J Infect Dis. 2011 Feb 15;203(4):545-8. doi: 10.1093/infdis/jiq086. Epub 2011 Jan 7.

Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii.

J Clin Microbiol. 2005 Feb;43(2):903-5. doi: 10.1128/JCM.43.2.903-905.2005.

Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii.

Virulence. 2018 Dec 31;9(1):930-942. doi: 10.1080/21505594.2018.1460187.

Colistin-resistant Acinetobacter baumannii ventilator-associated pneumonia in a tertiary care hospital: an evolving threat.

J Hosp Infect. 2016 Sep;94(1):72-3. doi: 10.1016/j.jhin.2016.04.014. Epub 2016 May 6.

In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.

Clin Microbiol Infect. 2012 Apr;18(4):383-7. doi: 10.1111/j.1469-0691.2011.03581.x. Epub 2011 Jun 14.

Intensified infection control measures to minimize the spread of colistin-resistant Acinetobacter baumannii.

Infect Control Hosp Epidemiol. 2013 Apr;34(4):445-7. doi: 10.1086/669959.

引用本文的文献

Synergistic action between peptide-neomycin conjugates and polymyxin B against multidrug-resistant gram-negative pathogens.

Front Microbiol. 2025 Aug 7;16:1605813. doi: 10.3389/fmicb.2025.1605813. eCollection 2025.

The Genetic Background and Culture Medium Only Marginally Affect the In Vitro Evolution of Toward Colistin Resistance.

Antibiotics (Basel). 2025 Jun 13;14(6):601. doi: 10.3390/antibiotics14060601.

Development, Characterization, and Antimicrobial Evaluation of Hybrid Nanoparticles (HNPs) Based on Phospholipids, Cholesterol, Colistin, and Chitosan Against Multidrug-Resistant Gram-Negative Bacteria.

Pharmaceutics. 2025 Feb 1;17(2):182. doi: 10.3390/pharmaceutics17020182.

Colistin Resistance Mechanism and Management Strategies of Colistin-Resistant Infections.

Pathogens. 2024 Nov 28;13(12):1049. doi: 10.3390/pathogens13121049.

Cyclic Peptide MV6, an Aminoglycoside Efficacy Enhancer Against .

Antibiotics (Basel). 2024 Dec 1;13(12):1147. doi: 10.3390/antibiotics13121147.

Discovery of new antimicrobial thiophene derivatives with activity against drug-resistant Gram negative-bacteria.

Front Pharmacol. 2024 Aug 20;15:1412797. doi: 10.3389/fphar.2024.1412797. eCollection 2024.

A New Pharmacokinetic-Pharmacodynamic Model To Characterize the Inoculum Effect of Acinetobacter baumannii on Polymyxin B .

Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0178921. doi: 10.1128/AAC.01789-21. Epub 2021 Nov 15.

Antimicrobial Resistance Mechanisms and Virulence of Colistin- and Carbapenem-Resistant Isolated from a Teaching Hospital in Taiwan.

Microorganisms. 2021 Jun 14;9(6):1295. doi: 10.3390/microorganisms9061295.

Cerebrospinal fluid (CSF) augments metabolism and virulence expression factors in Acinetobacter baumannii.

Sci Rep. 2021 Feb 26;11(1):4737. doi: 10.1038/s41598-021-81714-6.

Bacteremia by colistin-resistant Acinetobacter baumannii isolate: a case report.

J Med Case Rep. 2019 May 8;13(1):141. doi: 10.1186/s13256-019-2062-3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验